cellular process (GO:0009987) | 0.26 | 16 | CACNA1B, TOR1A, GCH1, KCTD17, PRKRA, ATP1A3, DRD2, SGCE, SLC2A1, THAP1, TAF1, ANO3, HPCA, TUBB4A, COL6A3, PNKD |
single-organism process (GO:0044699) | 0.48 | 16 | CACNA1B, TOR1A, GCH1, KCTD17, PRKRA, ATP1A3, DRD2, SGCE, SLC2A1, THAP1, TAF1, ANO3, HPCA, TUBB4A, COL6A3, PNKD |
biological regulation (GO:0065007) | 0.39 | 15 | CACNA1B, GNAL, GCH1, KCTD17, PRKRA, ATP1A3, DRD2, TOR1A, SLC2A1, THAP1, TAF1, ANO3, HPCA, COL6A3, PNKD |
regulation of biological process (GO:0050789) | 0.45 | 14 | CACNA1B, TOR1A, GCH1, GNAL, KCTD17, PRKRA, ATP1A3, DRD2, SLC2A1, THAP1, TAF1, HPCA, COL6A3, PNKD |
single-organism cellular process (GO:0044763) | 0.65 | 13 | ATP1A3, TOR1A, KCTD17, PRKRA, CACNA1B, DRD2, SLC2A1, THAP1, TAF1, ANO3, TUBB4A, COL6A3, PNKD |
regulation of cellular process (GO:0050794) | 0.5 | 13 | ATP1A3, TOR1A, GCH1, GNAL, KCTD17, PRKRA, DRD2, SLC2A1, THAP1, TAF1, HPCA, COL6A3, PNKD |
response to stimulus (GO:0050896) | 1.22 | 11 | CACNA1B, TOR1A, GCH1, PRKRA, PRRT2, ATP1A3, HPCA, SLC2A1, DRD2, ANO3, TAF1 |
organic substance metabolic process (GO:0071704) | 0.63 | 10 | TOR1A, GCH1, KCTD17, PRKRA, DRD2, SLC2A1, THAP1, TAF1, COL6A3, PNKD |
metabolic process (GO:0008152) | 0.58 | 10 | TOR1A, GCH1, KCTD17, PRKRA, DRD2, SLC2A1, THAP1, TAF1, COL6A3, PNKD |
multicellular organismal process (GO:0032501) | 1.45 | 9 | ATP1A3, GNAL, GCH1, COL6A3, PRRT2, CACNA1B, DRD2, SGCE, PNKD |
regulation of metabolic process (GO:0019222) | 1.02 | 9 | GNAL, GCH1, COL6A3, PRKRA, HPCA, THAP1, DRD2, TAF1, PNKD |
cellular metabolic process (GO:0044237) | 0.69 | 9 | TOR1A, GCH1, KCTD17, PRKRA, DRD2, SLC2A1, THAP1, TAF1, PNKD |
cellular component organization (GO:0016043) | 1.24 | 9 | ANO3, GCH1, KCTD17, DRD2, TOR1A, SLC2A1, TAF1, SGCE, COL6A3 |
regulation of biological quality (GO:0065008) | 1.68 | 9 | CACNA1B, TOR1A, GCH1, KCTD17, ATP1A3, DRD2, SLC2A1, ANO3, PNKD |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 9 | ANO3, GCH1, KCTD17, DRD2, TOR1A, SLC2A1, TAF1, SGCE, COL6A3 |
positive regulation of biological process (GO:0048518) | 1.2 | 8 | GNAL, TOR1A, KCTD17, PRKRA, DRD2, TAF1, HPCA, GCH1 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 8 | GNAL, GCH1, COL6A3, HPCA, THAP1, DRD2, TAF1, PNKD |
primary metabolic process (GO:0044238) | 0.69 | 7 | TOR1A, KCTD17, PRKRA, DRD2, SLC2A1, THAP1, TAF1 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 7 | GNAL, COL6A3, HPCA, THAP1, DRD2, TAF1, PNKD |
macromolecule metabolic process (GO:0043170) | 0.83 | 7 | TOR1A, KCTD17, PRKRA, DRD2, THAP1, TAF1, COL6A3 |
response to stress (GO:0006950) | 1.8 | 7 | CACNA1B, GCH1, TOR1A, PRKRA, DRD2, SLC2A1, TAF1 |
regulation of signaling (GO:0023051) | 1.72 | 7 | ATP1A3, TOR1A, PRKRA, DRD2, SLC2A1, TAF1, PNKD |
positive regulation of cellular process (GO:0048522) | 1.3 | 7 | GNAL, TOR1A, KCTD17, PRKRA, HPCA, DRD2, TAF1 |
system process (GO:0003008) | 2.3 | 7 | ATP1A3, GNAL, GCH1, PRRT2, DRD2, SGCE, PNKD |
establishment of localization (GO:0051234) | 1.48 | 6 | CACNA1B, TOR1A, ATP1A3, DRD2, SLC2A1, ANO3 |
regulation of localization (GO:0032879) | 1.94 | 6 | CACNA1B, TOR1A, HPCA, SLC2A1, DRD2, PNKD |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 6 | TOR1A, KCTD17, PRKRA, DRD2, THAP1, TAF1 |
regulation of transport (GO:0051049) | 2.24 | 6 | CACNA1B, TOR1A, HPCA, SLC2A1, DRD2, PNKD |
regulation of catalytic activity (GO:0050790) | 1.97 | 6 | GCH1, GNAL, COL6A3, PRKRA, HPCA, DRD2 |
single-organism transport (GO:0044765) | 2.18 | 6 | ATP1A3, TOR1A, CACNA1B, DRD2, SLC2A1, ANO3 |
cellular component assembly (GO:0022607) | 2.14 | 6 | GCH1, TOR1A, KCTD17, DRD2, SLC2A1, TAF1 |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 6 | GNAL, HPCA, THAP1, DRD2, TAF1, PNKD |
transport (GO:0006810) | 1.51 | 6 | CACNA1B, TOR1A, ATP1A3, DRD2, SLC2A1, ANO3 |
neurological system process (GO:0050877) | 2.64 | 6 | ATP1A3, GCH1, GNAL, PRRT2, DRD2, PNKD |
regulation of molecular function (GO:0065009) | 1.78 | 6 | GCH1, GNAL, COL6A3, PRKRA, HPCA, DRD2 |
regulation of cell communication (GO:0010646) | 1.73 | 6 | TOR1A, PRKRA, DRD2, SLC2A1, TAF1, PNKD |
localization (GO:0051179) | 1.4 | 6 | ATP1A3, TOR1A, CACNA1B, DRD2, SLC2A1, ANO3 |
single-organism localization (GO:1902578) | 2.09 | 6 | ATP1A3, TOR1A, CACNA1B, DRD2, SLC2A1, ANO3 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 5 | KCTD17, DRD2, TOR1A, HPCA, TAF1 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 5 | GCH1, DRD2, HPCA, GNAL, TAF1 |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 5 | SLC2A1, KCTD17, TOR1A, GCH1, TAF1 |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 5 | HPCA, TAF1, THAP1, DRD2, GNAL |
regulation of cellular component organization (GO:0051128) | 2.01 | 5 | HPCA, KCTD17, DRD2, TOR1A, TAF1 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 5 | PRKRA, TAF1, THAP1, DRD2, GCH1 |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 5 | HPCA, GCH1, PRKRA, DRD2, GNAL |
cellular response to stimulus (GO:0051716) | 1.97 | 5 | ATP1A3, PRKRA, TAF1, HPCA, SLC2A1 |
macromolecular complex assembly (GO:0065003) | 2.55 | 5 | TAF1, KCTD17, GCH1, TOR1A, SLC2A1 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 5 | PRKRA, COL6A3, THAP1, TAF1, DRD2 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 5 | PRKRA, TAF1, THAP1, DRD2, GCH1 |
positive regulation of molecular function (GO:0044093) | 2.23 | 5 | HPCA, GCH1, PRKRA, DRD2, GNAL |
negative regulation of biological process (GO:0048519) | 1.33 | 5 | HPCA, COL6A3, PRKRA, PNKD, DRD2 |
developmental process (GO:0032502) | 1.36 | 5 | SGCE, COL6A3, PRKRA, DRD2, HPCA |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 5 | TAF1, DRD2, THAP1, HPCA, GNAL |
regulation of biosynthetic process (GO:0009889) | 1.37 | 5 | HPCA, TAF1, THAP1, DRD2, GNAL |
ion transport (GO:0006811) | 2.66 | 5 | ANO3, CACNA1B, ATP1A3, DRD2, SLC2A1 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 5 | PRKRA, GCH1, THAP1, TAF1, DRD2 |
single-organism developmental process (GO:0044767) | 1.49 | 5 | SGCE, COL6A3, PRKRA, DRD2, HPCA |
response to chemical (GO:0042221) | 1.98 | 5 | GCH1, ATP1A3, PRKRA, DRD2, HPCA |
transmembrane transport (GO:0055085) | 2.72 | 5 | ANO3, CACNA1B, ATP1A3, DRD2, SLC2A1 |
response to abiotic stimulus (GO:0009628) | 2.8 | 5 | ANO3, ATP1A3, DRD2, HPCA, SLC2A1 |
single-multicellular organism process (GO:0044707) | 1.78 | 5 | CACNA1B, ATP1A3, DRD2, COL6A3, GCH1 |
response to external stimulus (GO:0009605) | 2.55 | 5 | ANO3, SLC2A1, PRKRA, DRD2, GCH1 |
negative regulation of cellular process (GO:0048523) | 1.41 | 5 | HPCA, COL6A3, PRKRA, PNKD, DRD2 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 4 | COL6A3, PRKRA, HPCA, DRD2 |
regulation of cellular localization (GO:0060341) | 3.03 | 4 | TOR1A, DRD2, PNKD, HPCA |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 4 | TAF1, DRD2, HPCA, GNAL |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 4 | HPCA, TAF1, DRD2, GNAL |
regulation of response to stimulus (GO:0048583) | 1.54 | 4 | TAF1, PRKRA, DRD2, GCH1 |
cellular biosynthetic process (GO:0044249) | 1.37 | 4 | SLC2A1, THAP1, TAF1, GCH1 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 4 | PRKRA, THAP1, GCH1, TAF1 |
signal transduction (GO:0007165) | 1.28 | 4 | ATP1A3, DRD2, HPCA, GNAL |
neuromuscular process (GO:0050905) | 5.27 | 4 | DRD2, PRRT2, PNKD, GCH1 |
regulation of protein localization (GO:0032880) | 2.88 | 4 | HPCA, SLC2A1, DRD2, TOR1A |
organic substance biosynthetic process (GO:1901576) | 1.34 | 4 | SLC2A1, THAP1, TAF1, GCH1 |
single-organism metabolic process (GO:0044710) | 1.63 | 4 | COL6A3, DRD2, PNKD, SLC2A1 |
protein complex subunit organization (GO:0071822) | 2.6 | 4 | KCTD17, TOR1A, GCH1, SLC2A1 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 4 | HPCA, TAF1, DRD2, GNAL |
organic substance transport (GO:0071702) | 2.15 | 4 | ANO3, SLC2A1, TOR1A, DRD2 |
regulation of gene expression (GO:0010468) | 1.37 | 4 | PRKRA, THAP1, TAF1, DRD2 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 4 | HPCA, TAF1, DRD2, GNAL |
protein complex assembly (GO:0006461) | 2.78 | 4 | KCTD17, TOR1A, GCH1, SLC2A1 |
ion transmembrane transport (GO:0034220) | 3.08 | 4 | ANO3, ATP1A3, CACNA1B, DRD2 |
biosynthetic process (GO:0009058) | 1.32 | 4 | SLC2A1, THAP1, TAF1, GCH1 |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 4 | HPCA, TAF1, DRD2, GNAL |
cell communication (GO:0007154) | 3.04 | 4 | CACNA1B, ATP1A3, DRD2, SLC2A1 |
catabolic process (GO:0009056) | 2.38 | 4 | KCTD17, COL6A3, PNKD, TOR1A |
response to organic substance (GO:0010033) | 2.2 | 4 | HPCA, ATP1A3, DRD2, GCH1 |
heterocycle metabolic process (GO:0046483) | 1.31 | 4 | PRKRA, THAP1, GCH1, TAF1 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 4 | ATP1A3, DRD2, HPCA, GCH1 |
protein metabolic process (GO:0019538) | 1.45 | 4 | KCTD17, PRKRA, TAF1, TOR1A |
anatomical structure development (GO:0048856) | 1.58 | 4 | HPCA, COL6A3, SGCE, DRD2 |
inorganic ion transmembrane transport (GO:0098660) | 3.38 | 4 | ANO3, ATP1A3, CACNA1B, DRD2 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 4 | TAF1, PRKRA, DRD2, GCH1 |
phosphorus metabolic process (GO:0006793) | 2.15 | 4 | TAF1, PRKRA, DRD2, GCH1 |
regulation of neurotransmitter levels (GO:0001505) | 4.77 | 4 | CACNA1B, DRD2, PNKD, TOR1A |
regulation of cyclic nucleotide metabolic process (GO:0030799) | 4.69 | 3 | HPCA, DRD2, GNAL |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 3 | HPCA, DRD2, GNAL |
regulation of secretion (GO:0051046) | 3.2 | 3 | SLC2A1, DRD2, PNKD |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 3 | THAP1, TAF1, DRD2 |
behavior (GO:0007610) | 3.47 | 3 | ATP1A3, CACNA1B, DRD2 |
membrane organization (GO:0061024) | 3.04 | 3 | ANO3, TOR1A, SGCE |
muscle system process (GO:0003012) | 4.18 | 3 | ATP1A3, DRD2, SGCE |
inorganic ion homeostasis (GO:0098771) | 3.43 | 3 | ATP1A3, KCTD17, DRD2 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 3 | THAP1, TAF1, GCH1 |
regulation of signal transduction (GO:0009966) | 1.84 | 3 | PRKRA, TAF1, DRD2 |
animal organ development (GO:0048513) | 2.53 | 3 | COL6A3, SGCE, HPCA |
negative regulation of molecular function (GO:0044092) | 2.74 | 3 | COL6A3, HPCA, DRD2 |
cellular homeostasis (GO:0019725) | 3.23 | 3 | KCTD17, ATP1A3, DRD2 |
positive regulation of transport (GO:0051050) | 2.9 | 3 | DRD2, TOR1A, HPCA |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 3 | THAP1, TAF1, DRD2 |
regulation of cyclase activity (GO:0031279) | 5.32 | 3 | DRD2, HPCA, GNAL |
regulation of synaptic transmission, dopaminergic (GO:0032225) | 6.9 | 3 | DRD2, PNKD, TOR1A |
response to biotic stimulus (GO:0009607) | 3.09 | 3 | PRRT2, PRKRA, GCH1 |
anion transport (GO:0006820) | 3.71 | 3 | SLC2A1, ANO3, DRD2 |
regulation of purine nucleotide biosynthetic process (GO:1900371) | 4.8 | 3 | DRD2, HPCA, GNAL |
cellular response to stress (GO:0033554) | 2.51 | 3 | SLC2A1, PRKRA, TAF1 |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 3 | THAP1, TAF1, GCH1 |
chemical homeostasis (GO:0048878) | 2.97 | 3 | KCTD17, ATP1A3, DRD2 |
regulation of neurotransmitter transport (GO:0051588) | 5.55 | 3 | TOR1A, PNKD, DRD2 |
regulation of protein transport (GO:0051223) | 3.12 | 3 | SLC2A1, HPCA, DRD2 |
cellular protein metabolic process (GO:0044267) | 1.63 | 3 | PRKRA, TAF1, TOR1A |
organic substance catabolic process (GO:1901575) | 2.45 | 3 | KCTD17, TOR1A, PNKD |
inorganic cation transmembrane transport (GO:0098662) | 3.55 | 3 | CACNA1B, ATP1A3, DRD2 |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 3 | THAP1, TAF1, GCH1 |
locomotory behavior (GO:0007626) | 4.53 | 3 | CACNA1B, ATP1A3, DRD2 |
regulation of establishment of protein localization (GO:0070201) | 3.02 | 3 | SLC2A1, DRD2, HPCA |
cation transport (GO:0006812) | 3.11 | 3 | ATP1A3, CACNA1B, DRD2 |
regulation of heart contraction (GO:0008016) | 4.35 | 3 | ATP1A3, CACNA1B, DRD2 |
macromolecule modification (GO:0043412) | 1.73 | 3 | PRKRA, TAF1, TOR1A |
protein modification process (GO:0036211) | 1.79 | 3 | PRKRA, TAF1, TOR1A |
regulation of blood circulation (GO:1903522) | 4.05 | 3 | ATP1A3, CACNA1B, DRD2 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 3 | ATP1A3, CACNA1B, DRD2 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 3 | PRKRA, TAF1, DRD2 |
regulation of hydrolase activity (GO:0051336) | 2.53 | 3 | COL6A3, DRD2, HPCA |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 3 | THAP1, TAF1, GCH1 |
regulation of lyase activity (GO:0051339) | 5.3 | 3 | DRD2, HPCA, GNAL |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 3 | THAP1, TAF1, DRD2 |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 3 | THAP1, TAF1, DRD2 |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 3 | HPCA, DRD2, GNAL |
ion homeostasis (GO:0050801) | 3.42 | 3 | ATP1A3, KCTD17, DRD2 |
metal ion homeostasis (GO:0055065) | 3.61 | 3 | KCTD17, ATP1A3, DRD2 |
modulation of synaptic transmission (GO:0050804) | 4.09 | 3 | DRD2, PNKD, TOR1A |
cellular catabolic process (GO:0044248) | 2.62 | 3 | KCTD17, TOR1A, PNKD |
regulation of secretion by cell (GO:1903530) | 3.28 | 3 | SLC2A1, DRD2, PNKD |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 3 | ATP1A3, PRKRA, HPCA |
negative regulation of catalytic activity (GO:0043086) | 3.0 | 3 | COL6A3, DRD2, HPCA |
response to organic cyclic compound (GO:0014070) | 3.07 | 3 | ATP1A3, DRD2, HPCA |
response to endogenous stimulus (GO:0009719) | 2.79 | 3 | ATP1A3, DRD2, HPCA |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 3 | PRKRA, THAP1, TAF1 |
regulation of system process (GO:0044057) | 3.53 | 3 | ATP1A3, CACNA1B, DRD2 |
neuromuscular process controlling posture (GO:0050884) | 7.24 | 3 | PRRT2, GCH1, PNKD |
regulation of cAMP biosynthetic process (GO:0030817) | 5.01 | 3 | DRD2, HPCA, GNAL |
regulation of cAMP metabolic process (GO:0030814) | 4.88 | 3 | DRD2, HPCA, GNAL |
regulation of protein metabolic process (GO:0051246) | 1.93 | 3 | COL6A3, TAF1, DRD2 |
biological adhesion (GO:0022610) | 2.81 | 3 | COL6A3, TOR1A, SGCE |
RNA metabolic process (GO:0016070) | 1.59 | 3 | PRKRA, THAP1, TAF1 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 3 | ATP1A3, KCTD17, DRD2 |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 3 | THAP1, TAF1, DRD2 |
metal ion transport (GO:0030001) | 3.36 | 3 | ATP1A3, CACNA1B, DRD2 |
cellular cation homeostasis (GO:0030003) | 3.6 | 3 | ATP1A3, KCTD17, DRD2 |
cation homeostasis (GO:0055080) | 3.46 | 3 | ATP1A3, KCTD17, DRD2 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 3 | ATP1A3, KCTD17, DRD2 |
protein oligomerization (GO:0051259) | 3.71 | 3 | KCTD17, TOR1A, GCH1 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 3 | PRKRA, THAP1, TAF1 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 3 | COL6A3, TAF1, DRD2 |
regulation of nucleotide biosynthetic process (GO:0030808) | 4.79 | 3 | HPCA, DRD2, GNAL |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 3 | THAP1, TAF1, DRD2 |
regulation of cyclic nucleotide biosynthetic process (GO:0030802) | 4.85 | 3 | DRD2, HPCA, GNAL |
cell projection organization (GO:0030030) | 3.14 | 3 | KCTD17, DRD2, TOR1A |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 3 | COL6A3, HPCA, DRD2 |
homeostatic process (GO:0042592) | 2.61 | 3 | KCTD17, ATP1A3, DRD2 |
regulation of blood pressure (GO:0008217) | 4.72 | 3 | CACNA1B, DRD2, GCH1 |
regulation of adenylate cyclase activity (GO:0045761) | 5.51 | 3 | HPCA, DRD2, GNAL |
protein homooligomerization (GO:0051260) | 4.21 | 3 | KCTD17, GCH1, TOR1A |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 3 | DRD2, HPCA, GNAL |
cellular protein modification process (GO:0006464) | 1.79 | 3 | PRKRA, TAF1, TOR1A |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 3 | HPCA, DRD2, GNAL |
cellular ion homeostasis (GO:0006873) | 3.57 | 3 | KCTD17, ATP1A3, DRD2 |
establishment of localization in cell (GO:0051649) | 2.47 | 3 | CACNA1B, TOR1A, DRD2 |
cell adhesion (GO:0007155) | 2.82 | 3 | COL6A3, TOR1A, SGCE |
regulation of purine nucleotide metabolic process (GO:1900542) | 4.41 | 3 | HPCA, DRD2, GNAL |
regulation of nucleotide metabolic process (GO:0006140) | 4.38 | 3 | DRD2, HPCA, GNAL |
cation transmembrane transport (GO:0098655) | 3.43 | 3 | CACNA1B, ATP1A3, DRD2 |
regulation of peptide transport (GO:0090087) | 4.37 | 2 | SLC2A1, DRD2 |
protein localization (GO:0008104) | 2.36 | 2 | DRD2, TOR1A |
negative regulation of secretion (GO:0051048) | 4.44 | 2 | DRD2, PNKD |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | PRKRA, DRD2 |
learning (GO:0007612) | 4.85 | 2 | ATP1A3, DRD2 |
memory (GO:0007613) | 5.13 | 2 | ATP1A3, DRD2 |
learning or memory (GO:0007611) | 4.33 | 2 | ATP1A3, DRD2 |
small molecule metabolic process (GO:0044281) | 2.38 | 2 | SLC2A1, PNKD |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | ATP1A3, DRD2 |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 2 | CACNA1B, DRD2 |
positive regulation of receptor-mediated endocytosis (GO:0048260) | 5.84 | 2 | TOR1A, DRD2 |
negative regulation of nucleotide metabolic process (GO:0045980) | 5.6 | 2 | DRD2, HPCA |
positive regulation of nucleotide metabolic process (GO:0045981) | 4.85 | 2 | HPCA, GNAL |
regulation of transmembrane transport (GO:0034762) | 3.74 | 2 | CACNA1B, DRD2 |
response to pain (GO:0048265) | 6.78 | 2 | CACNA1B, GCH1 |
single-organism catabolic process (GO:0044712) | 3.21 | 2 | COL6A3, PNKD |
regulation of insulin secretion (GO:0050796) | 4.57 | 2 | SLC2A1, DRD2 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | COL6A3, PRKRA |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | TAF1, DRD2 |
response to external biotic stimulus (GO:0043207) | 3.13 | 2 | PRKRA, GCH1 |
dopamine receptor signaling pathway (GO:0007212) | 6.26 | 2 | DRD2, GNAL |
positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | PRKRA, DRD2 |
interspecies interaction between organisms (GO:0044419) | 3.08 | 2 | PRKRA, TAF1 |
phosphorylation (GO:0016310) | 2.63 | 2 | PRKRA, TAF1 |
regulation of amine transport (GO:0051952) | 5.62 | 2 | TOR1A, DRD2 |
macromolecule localization (GO:0033036) | 2.34 | 2 | TOR1A, DRD2 |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | PRKRA, DRD2 |
sensory perception of smell (GO:0007608) | 3.61 | 2 | DRD2, GNAL |
negative regulation of transport (GO:0051051) | 3.6 | 2 | DRD2, PNKD |
sensory perception of chemical stimulus (GO:0007606) | 3.49 | 2 | DRD2, GNAL |
organic anion transport (GO:0015711) | 4.07 | 2 | SLC2A1, DRD2 |
regulation of peptide hormone secretion (GO:0090276) | 4.41 | 2 | SLC2A1, DRD2 |
regulation of proteolysis (GO:0030162) | 3.2 | 2 | COL6A3, TAF1 |
protein catabolic process (GO:0030163) | 3.93 | 2 | KCTD17, TOR1A |
signaling (GO:0023052) | 3.25 | 2 | CACNA1B, DRD2 |
oxoacid metabolic process (GO:0043436) | 3.12 | 2 | SLC2A1, PNKD |
negative regulation of nucleotide biosynthetic process (GO:0030809) | 6.07 | 2 | DRD2, HPCA |
multi-organism process (GO:0051704) | 2.65 | 2 | PRKRA, TAF1 |
single organism signaling (GO:0044700) | 3.25 | 2 | CACNA1B, DRD2 |
organonitrogen compound metabolic process (GO:1901564) | 2.32 | 2 | DRD2, GCH1 |
vesicle-mediated transport (GO:0016192) | 2.72 | 2 | TOR1A, DRD2 |
cell motility (GO:0048870) | 3.02 | 2 | TOR1A, DRD2 |
single-organism behavior (GO:0044708) | 3.79 | 2 | ATP1A3, DRD2 |
response to organonitrogen compound (GO:0010243) | 3.2 | 2 | DRD2, HPCA |
negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 6.07 | 2 | HPCA, DRD2 |
positive regulation of purine nucleotide biosynthetic process (GO:1900373) | 5.09 | 2 | HPCA, GNAL |
anterograde trans-synaptic signaling (GO:0098916) | 3.98 | 2 | CACNA1B, DRD2 |
multicellular organismal response to stress (GO:0033555) | 5.67 | 2 | CACNA1B, GCH1 |
organophosphate metabolic process (GO:0019637) | 3.04 | 2 | DRD2, GCH1 |
negative regulation of secretion by cell (GO:1903531) | 4.55 | 2 | DRD2, PNKD |
calcium ion homeostasis (GO:0055074) | 3.97 | 2 | KCTD17, DRD2 |
regulation of membrane potential (GO:0042391) | 3.89 | 2 | CACNA1B, ATP1A3 |
visual behavior (GO:0007632) | 5.82 | 2 | ATP1A3, DRD2 |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 2 | HPCA, DRD2 |
positive regulation of cyclic nucleotide metabolic process (GO:0030801) | 5.05 | 2 | HPCA, GNAL |
movement of cell or subcellular component (GO:0006928) | 2.61 | 2 | DRD2, TOR1A |
regulation of neurotransmitter uptake (GO:0051580) | 7.02 | 2 | DRD2, TOR1A |
positive regulation of gene expression (GO:0010628) | 2.35 | 2 | TAF1, DRD2 |
regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 7.65 | 2 | TOR1A, DRD2 |
intracellular signal transduction (GO:0035556) | 2.39 | 2 | HPCA, DRD2 |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 2 | THAP1, TAF1 |
cellular macromolecule catabolic process (GO:0044265) | 3.19 | 2 | KCTD17, TOR1A |
regulation of protein secretion (GO:0050708) | 3.77 | 2 | SLC2A1, DRD2 |
positive regulation of lyase activity (GO:0051349) | 5.65 | 2 | HPCA, GNAL |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188) | 4.78 | 2 | DRD2, GNAL |
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 5.52 | 2 | DRD2, GNAL |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 2 | TAF1, DRD2 |
cell migration (GO:0016477) | 3.12 | 2 | TOR1A, DRD2 |
G-protein coupled receptor signaling pathway (GO:0007186) | 2.64 | 2 | DRD2, GNAL |
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) | 4.6 | 2 | DRD2, GNAL |
regulation of developmental process (GO:0050793) | 2.1 | 2 | KCTD17, DRD2 |
catecholamine metabolic process (GO:0006584) | 6.02 | 2 | DRD2, GCH1 |
calcium ion transport (GO:0006816) | 4.33 | 2 | CACNA1B, DRD2 |
associative learning (GO:0008306) | 5.44 | 2 | ATP1A3, DRD2 |
single-organism membrane organization (GO:0044802) | 3.19 | 2 | ANO3, TOR1A |
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 7.65 | 2 | TOR1A, DRD2 |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | THAP1, TAF1 |
positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 2 | PRKRA, DRD2 |
regulation of receptor-mediated endocytosis (GO:0048259) | 5.35 | 2 | DRD2, TOR1A |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 2 | THAP1, TAF1 |
proteolysis involved in cellular protein catabolic process (GO:0051603) | 3.59 | 2 | KCTD17, TOR1A |
secretion (GO:0046903) | 3.38 | 2 | CACNA1B, DRD2 |
regulation of response to stress (GO:0080134) | 2.53 | 2 | DRD2, GCH1 |
proteasomal protein catabolic process (GO:0010498) | 4.12 | 2 | KCTD17, TOR1A |
sensory perception (GO:0007600) | 2.93 | 2 | DRD2, GNAL |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 2 | TAF1, DRD2 |
ubiquitin-dependent protein catabolic process (GO:0006511) | 3.72 | 2 | KCTD17, TOR1A |
transcription, DNA-templated (GO:0006351) | 1.91 | 2 | THAP1, TAF1 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 5.48 | 2 | DRD2, GNAL |
synaptic signaling (GO:0099536) | 3.98 | 2 | CACNA1B, DRD2 |
trans-synaptic signaling (GO:0099537) | 3.98 | 2 | CACNA1B, DRD2 |
catechol-containing compound metabolic process (GO:0009712) | 6.02 | 2 | DRD2, GCH1 |
RNA biosynthetic process (GO:0032774) | 1.84 | 2 | THAP1, TAF1 |
lipid transport (GO:0006869) | 4.24 | 2 | ANO3, DRD2 |
response to radiation (GO:0009314) | 3.69 | 2 | ATP1A3, DRD2 |
negative regulation of synaptic transmission (GO:0050805) | 5.67 | 2 | DRD2, PNKD |
regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | TOR1A, HPCA |
negative regulation of signaling (GO:0023057) | 2.65 | 2 | DRD2, PNKD |
response to light stimulus (GO:0009416) | 4.08 | 2 | ATP1A3, DRD2 |
negative regulation of cell communication (GO:0010648) | 2.66 | 2 | DRD2, PNKD |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 2 | THAP1, TAF1 |
muscle structure development (GO:0061061) | 4.96 | 2 | COL6A3, SGCE |
positive regulation of cell communication (GO:0010647) | 2.41 | 2 | PRKRA, DRD2 |
positive regulation of establishment of protein localization (GO:1904951) | 3.49 | 2 | HPCA, DRD2 |
visual learning (GO:0008542) | 5.92 | 2 | ATP1A3, DRD2 |
cell cycle (GO:0007049) | 3.14 | 2 | THAP1, TAF1 |
divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 2 | KCTD17, DRD2 |
cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 2 | KCTD17, DRD2 |
positive regulation of cAMP biosynthetic process (GO:0030819) | 5.35 | 2 | HPCA, GNAL |
positive regulation of cAMP metabolic process (GO:0030816) | 5.25 | 2 | HPCA, GNAL |
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) | 4.16 | 2 | KCTD17, TOR1A |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 2 | HPCA, DRD2 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | TAF1, DRD2 |
positive regulation of nucleotide biosynthetic process (GO:0030810) | 5.09 | 2 | HPCA, GNAL |
macromolecule catabolic process (GO:0009057) | 3.0 | 2 | KCTD17, TOR1A |
muscle organ development (GO:0007517) | 4.98 | 2 | COL6A3, SGCE |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | TAF1, DRD2 |
proteolysis (GO:0006508) | 2.73 | 2 | KCTD17, TOR1A |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 2 | TAF1, DRD2 |
negative regulation of cell proliferation (GO:0008285) | 3.26 | 2 | PRKRA, DRD2 |
cognition (GO:0050890) | 4.2 | 2 | ATP1A3, DRD2 |
cellular calcium ion homeostasis (GO:0006874) | 4.01 | 2 | KCTD17, DRD2 |
modification-dependent protein catabolic process (GO:0019941) | 3.71 | 2 | KCTD17, TOR1A |
regulation of vesicle-mediated transport (GO:0060627) | 3.63 | 2 | TOR1A, DRD2 |
dopamine metabolic process (GO:0042417) | 6.51 | 2 | DRD2, GCH1 |
regulation of hormone secretion (GO:0046883) | 4.18 | 2 | SLC2A1, DRD2 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 2 | TAF1, DRD2 |
phenol-containing compound metabolic process (GO:0018958) | 5.33 | 2 | DRD2, GCH1 |
response to oxidative stress (GO:0006979) | 3.9 | 2 | PRKRA, TOR1A |
negative regulation of lyase activity (GO:0051350) | 6.43 | 2 | HPCA, DRD2 |
divalent metal ion transport (GO:0070838) | 4.15 | 2 | CACNA1B, DRD2 |
organic acid metabolic process (GO:0006082) | 3.01 | 2 | SLC2A1, PNKD |
positive regulation of developmental process (GO:0051094) | 2.77 | 2 | KCTD17, DRD2 |
positive regulation of cyclic nucleotide biosynthetic process (GO:0030804) | 5.14 | 2 | HPCA, GNAL |
response to drug (GO:0042493) | 3.71 | 2 | ATP1A3, DRD2 |
negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 5.99 | 2 | DRD2, HPCA |
negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 6.12 | 2 | DRD2, HPCA |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 2 | TAF1, DRD2 |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 2 | TAF1, DRD2 |
negative regulation of blood pressure (GO:0045776) | 5.99 | 2 | DRD2, GCH1 |
response to nitrogen compound (GO:1901698) | 3.12 | 2 | DRD2, HPCA |
negative regulation of cyclase activity (GO:0031280) | 6.51 | 2 | HPCA, DRD2 |
positive regulation of cyclase activity (GO:0031281) | 5.65 | 2 | HPCA, GNAL |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 2 | HPCA, DRD2 |
divalent inorganic cation transport (GO:0072511) | 4.13 | 2 | CACNA1B, DRD2 |
calcium ion transmembrane transport (GO:0070588) | 4.67 | 2 | CACNA1B, DRD2 |
carboxylic acid metabolic process (GO:0019752) | 3.12 | 2 | SLC2A1, PNKD |
modification-dependent macromolecule catabolic process (GO:0043632) | 3.69 | 2 | KCTD17, TOR1A |
positive regulation of protein transport (GO:0051222) | 3.61 | 2 | DRD2, HPCA |
regulation of ion transport (GO:0043269) | 3.4 | 2 | CACNA1B, DRD2 |
muscle contraction (GO:0006936) | 4.37 | 2 | ATP1A3, DRD2 |
response to lipid (GO:0033993) | 3.11 | 2 | ATP1A3, GCH1 |
positive regulation of adenylate cyclase activity (GO:0045762) | 5.9 | 2 | HPCA, GNAL |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 2 | TAF1, DRD2 |
protein phosphorylation (GO:0006468) | 2.89 | 2 | PRKRA, TAF1 |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | HPCA, DRD2 |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 2 | HPCA, DRD2 |
regulation of hormone levels (GO:0010817) | 3.56 | 2 | SLC2A1, DRD2 |
regulation of metal ion transport (GO:0010959) | 3.94 | 2 | CACNA1B, DRD2 |
multi-organism cellular process (GO:0044764) | 3.14 | 2 | PRKRA, TAF1 |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 2 | HPCA, DRD2 |
chemical synaptic transmission (GO:0007268) | 3.98 | 2 | CACNA1B, DRD2 |
cell-cell signaling (GO:0007267) | 3.35 | 2 | CACNA1B, DRD2 |
regulation of endocytosis (GO:0030100) | 4.42 | 2 | DRD2, TOR1A |
adult locomotory behavior (GO:0008344) | 5.3 | 2 | ATP1A3, DRD2 |
positive regulation of signaling (GO:0023056) | 2.41 | 2 | PRKRA, DRD2 |
locomotion (GO:0040011) | 2.91 | 2 | DRD2, TOR1A |
adult behavior (GO:0030534) | 4.79 | 2 | ATP1A3, DRD2 |
negative regulation of purine nucleotide metabolic process (GO:1900543) | 5.62 | 2 | DRD2, HPCA |
positive regulation of purine nucleotide metabolic process (GO:1900544) | 4.85 | 2 | HPCA, GNAL |
regulation of cell cycle (GO:0051726) | 2.93 | 2 | THAP1, DRD2 |
regulation of peptide secretion (GO:0002791) | 4.38 | 2 | SLC2A1, DRD2 |
regulation of calcium ion transport (GO:0051924) | 4.38 | 2 | CACNA1B, DRD2 |
regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | KCTD17, TAF1 |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | PRKRA, DRD2 |
viral process (GO:0016032) | 3.15 | 2 | PRKRA, TAF1 |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 2 | PRKRA, TAF1 |
positive regulation of endocytosis (GO:0045807) | 4.98 | 2 | DRD2, TOR1A |
organic hydroxy compound metabolic process (GO:1901615) | 3.84 | 2 | DRD2, GCH1 |
positive regulation of cellular component biogenesis (GO:0044089) | 3.71 | 2 | KCTD17, TAF1 |